Latest news
Showing 11/35 results
Farxiga granted Breakthrough Therapy Designation in US for chronic kidney disease
Wed 7 Oct 2020
AstraZeneca
COVID-19 vaccine AZD1222 clinical trials resumed in the UK
Tue 15 Sep 2020
AstraZeneca
AstraZeneca’s scientific and social commitment for COVID-19 vaccine
Tue 1 Sep 2020
AstraZeneca
Imfinzi approved in Japan for the treatment of extensive-stage small cell lung cancer
Mon 24 Aug 2020
AstraZeneca
AstraZeneca concludes agreement with the European Commission for the supply of up to 400 million doses of AZD1222 COVID-19 vaccine
Wed 19 Aug 2020
AstraZeneca
COVID-19 vaccine AZD1222 showed robust immune responses in all participants in Phase I/II trial
Tue 21 Jul 2020
AstraZeneca
Selumetinib granted orphan drug designation in Japan for neurofibromatosis type 1
Mon 6 Jul 2020
AstraZeneca
AstraZeneca to supply Europe with up to 400 million doses of Oxford University’s vaccine at no profit
Thu 18 Jun 2020
AstraZeneca
AstraZeneca to discover and develop novel therapies targeting RNA-modifying proteins in oncology collaboration with Accent Therapeutics
Thu 4 Jun 2020
AstraZeneca
AstraZeneca collaborates with ArcherDX to use personalised cancer assays to detect minimal residual disease in lung cancer trials
Wed 27 May 2020
AstraZeneca
AstraZeneca advances the science of cancer medicine with practice-changing data at the ASCO20 Virtual Scientific Program
Wed 20 May 2020
AstraZeneca